SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Jul-24 5:24 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 29-Jul-24 | Sale | 2,251 | $5.92 | $13,326.60 | (< 1%) 231.65K to 229.4K | |
06-Mar-24 4:46 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 8,902 | $4.20 | $37,410.70 | (4%) 240.55K to 231.65K | |
06-Mar-24 4:46 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 5,798 | $4.48 | $25,982.00 | (2%) 246.35K to 240.55K | |
21-Feb-24 4:52 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 125,000 | -- | -- | 103% 121.35K to 246.35K | |
01-Aug-23 4:30 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Jul-23 | Sale | 2,212 | $6.30 | $13,944.60 | (2%) 123.56K to 121.35K | |
20-Jun-23 4:34 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Jun-23 | Sale | 16,000 | $6.29 | $100,710.00 | (11%) 139.56K to 123.56K | |
06-Mar-23 6:25 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 5,968 | $6.28 | $37,498.70 | (4%) 145.53K to 139.56K | |
06-Mar-23 6:25 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 7,966 | $6.26 | $49,845.70 | (5%) 153.5K to 145.53K | |
21-Feb-23 6:09 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 27% 120.8K to 153.5K | |
07-Dec-22 5:56 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Exercise | 7,500 | $3.12 | $23,400.00 | 6% 118.09K to 125.59K | |
07-Dec-22 5:56 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Sale | 4,792 | $10.61 | $50,826.80 | (4%) 125.59K to 120.8K | |
01-Aug-22 4:45 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Jul-22 | Sale | 2,239 | $10.97 | $24,561.80 | (2%) 120.33K to 118.09K | |
02-Mar-22 9:27 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-22 | Sale | 8,832 | $11.28 | $99,649.70 | (7%) 129.16K to 120.33K | |
02-Mar-22 9:27 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 01-Mar-22 | Sale | 3,473 | $11.19 | $38,862.90 | (3%) 132.63K to 129.16K | |
02-Mar-22 9:27 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Feb-22 | Grant | 32,700 | -- | -- | 33% 99.93K to 132.63K | |
30-Jul-21 9:15 AM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Jul-21 | Market Sale | 2,130 | $19.24 | $40,972.90 | (2%) 102.06K to 99.93K | 7% |
03-Mar-21 6:40 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-21 | Market Sale | 6,044 | $18.23 | $110,191.00 | (6%) 108.11K to 102.06K | 2% |
03-Mar-21 6:40 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 01-Mar-21 | Market Sale | 3,327 | $18.57 | $61,780.10 | (3%) 111.43K to 108.11K | 3% |
26-Feb-21 5:17 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 24-Feb-21 | Grant | 32,700 | -- | -- | 42% 78.73K to 111.43K | |
29-Jul-20 8:19 PM View: | Vanda Pharmaceuticals, Inc. (VNDA) | 27-Jul-20 | Grant | 17,344 | -- | -- | 28% 61.39K to 78.73K |